Skip to main content
Fig. 1 | BMC Neurology

Fig. 1

From: A case report of neuromyelitis optica spectrum disorder induced by pembrolizumab treatment for lung adenocarcinoma: a clinical and immunohistochemical study

Fig. 1

Transaxial brain magnetic resonance imaging (MRI) 1 month after neurological onset, showing T2 high intensity lesion in (A) the right cerebral peduncle, (B) diencephalon to (C) thalamus, adjacent to the third ventricle with (D) gadolinium enhancement. Spinal cord MRI 2 months after neurological onset showing short inversion recovery (STIR) images on (E) sagittal and (F) transaxial plane with bright spotty lesion at T3 level

Back to article page